Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 3Rectal Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Prostate Cancer, Hereditary, 7 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Muscle Weakness 1Health Status Unknown 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1Astrocytoma 1Anus Neoplasms 1

Interventions

Temozolomide 18Radiation 7Magnetic Resonance Spectroscopy 7Radiotherapy 6Specimen Handling 4Lomustine 4Bevacizumab 4Aminolevulinic Acid 3veliparib 2trametinib 2lutetium Lu 177 dotatate 2dabrafenib 2azeliragon 2Surgical Procedures, Operative 2Receptors, Interleukin-8B 2Nivolumab 2D2C7-(scdsFv)-PE38KDEL 2Carboplatin 2Biopsy 2varlilumab 1ulixertinib 1tinostamustine 1selinexor 1ruxolitinib 1ribociclib 1relatlimab 1regorafenib 1peposertib 1pembrolizumab 1olaparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioblastoma × Magnetic Resonance Imaging × 30 days × Clear all
NCT07223034 2026-06-04

A Study of 177Lu-PSMA-617 in People With Gliomas

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
20 enrolled
CNS

Astrocytoma, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡